Mordenti J - Search Results

1

Altered pharmacokinetics of recombinant human deoxyribonuclease in rats due to the presence of a binding protein.

Mohler M, Cook J, Lewis D, Moore J, Sinicropi D, Championsmith A, Ferraiolo B, Mordenti J. Mohler M, et al. Among authors: mordenti j. Drug Metab Dispos. 1993 Jan-Feb;21(1):71-5. Drug Metab Dispos. 1993. PMID: 8095230

2

Interspecies scaling of clearance and volume of distribution data for five therapeutic proteins.

Mordenti J, Chen SA, Moore JA, Ferraiolo BL, Green JD. Mordenti J, et al. Pharm Res. 1991 Nov;8(11):1351-9. doi: 10.1023/a:1015836720294. Pharm Res. 1991. PMID: 1798669

3

Pharmacokinetics and tissue distribution of recombinant human transforming growth factor beta 1 after topical and intravenous administration in male rats.

Zioncheck TF, Chen SA, Richardson L, Mora-Worms M, Lucas C, Lewis D, Green JD, Mordenti J. Zioncheck TF, et al. Among authors: mordenti j. Pharm Res. 1994 Feb;11(2):213-20. doi: 10.1023/a:1018995005775. Pharm Res. 1994. PMID: 8165178

4

Pharmacokinetics and interspecies scaling of recombinant human factor VIII.

Mordenti J, Osaka G, Garcia K, Thomsen K, Licko V, Meng G. Mordenti J, et al. Toxicol Appl Pharmacol. 1996 Jan;136(1):75-8. doi: 10.1006/taap.1996.0008. Toxicol Appl Pharmacol. 1996. PMID: 8560482

5

The pharmacokinetics and absorption of recombinant human relaxin in nonpregnant rabbits and rhesus monkeys after intravenous and intravaginal administration.

Chen SA, Reed B, Nguyen T, Gaylord N, Fuller GB, Mordenti J. Chen SA, et al. Among authors: mordenti j. Pharm Res. 1993 Feb;10(2):223-7. doi: 10.1023/a:1018982726441. Pharm Res. 1993. PMID: 8456068

6

Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125I-labeled full-length and Fab antibodies in rhesus monkeys following intravitreal administration.

Mordenti J, Cuthbertson RA, Ferrara N, Thomsen K, Berleau L, Licko V, Allen PC, Valverde CR, Meng YG, Fei DT, Fourre KM, Ryan AM. Mordenti J, et al. Toxicol Pathol. 1999 Sep-Oct;27(5):536-44. doi: 10.1177/019262339902700507. Toxicol Pathol. 1999. PMID: 10528633

7

Modification of CD4 immunoadhesin with monomethoxypoly(ethylene glycol) aldehyde via reductive alkylation.

Chamow SM, Kogan TP, Venuti M, Gadek T, Harris RJ, Peers DH, Mordenti J, Shak S, Ashkenazi A. Chamow SM, et al. Among authors: mordenti j. Bioconjug Chem. 1994 Mar-Apr;5(2):133-40. doi: 10.1021/bc00026a005. Bioconjug Chem. 1994. PMID: 8031876

8

Design of biological equivalence programs for therapeutic biotechnology products in clinical development: a perspective.

Mordenti J, Cavagnaro JA, Green JD. Mordenti J, et al. Pharm Res. 1996 Oct;13(10):1427-37. doi: 10.1023/a:1016002823485. Pharm Res. 1996. PMID: 8899831 Review.

9

The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase 1 study.

Kahn JO, Allan JD, Hodges TL, Kaplan LD, Arri CJ, Fitch HF, Izu AE, Mordenti J, Sherwin JE, Groopman JE, et al. Kahn JO, et al. Among authors: mordenti j. Ann Intern Med. 1990 Feb 15;112(4):254-61. doi: 10.7326/0003-4819-112-4-. Ann Intern Med. 1990. PMID: 2297204

10

Pharmacokinetics, tissue distribution, and expression efficiency of plasmid [33P]DNA following intravenous administration of DNA/cationic lipid complexes in mice: use of a novel radionuclide approach.

Osaka G, Carey K, Cuthbertson A, Godowski P, Patapoff T, Ryan A, Gadek T, Mordenti J. Osaka G, et al. Among authors: mordenti j. J Pharm Sci. 1996 Jun;85(6):612-8. doi: 10.1021/js9504494. J Pharm Sci. 1996. PMID: 8773958

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters